American Sycamore Pollen

NDC 22840-5472 · Greer Laboratories, Inc.

Generic namePlatanus occidentalis

Dosage formSOLUTION

RouteINTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS

Active ingredient(s)PLATANUS OCCIDENTALIS POLLEN

Strength.05 g/mL

Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Pollen Allergenic Extract [EPC], Pollen [CS]

Marketing categoryBLA

Packages

22840-5472-2 — 10 mL in 1 VIAL, MULTI-DOSE (22840-5472-2)

22840-5472-4 — 50 mL in 1 VIAL, MULTI-DOSE (22840-5472-4)

22840-5472-5 — 5 mL in 1 BOTTLE, DROPPER (22840-5472-5)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0268-1501 — Sycamore American, 0268-1502 — Sycamore American, 0268-6672 — American Sycamore, 22840-3487 — Platanus occidentalis, 22840-3488 — Platanus occidentalis, 22840-3489 — Platanus occidentalis, 22840-3490 — Platanus occidentalis, 22840-3491 — Platanus occidentalis, 49643-391 — Platanus occidentalis, 65044-2563 — Sycamore, American Eastern Platanus occidentallis, 65044-2564 — Sycamore, American Eastern Platanus occidentallis

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels